Stocktoria

Penumbra Inc PEN

NYSE · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2015-09-18 · LEI

Penumbra Inc financials (annual)

Revenue
$263.3M $333.8M $444.9M $547.4M $560.4M $747.6M $847.1M $1.06B $1.19B $1.40B 2016201720182019202020212022202320242025
Net income
$14.8M $4.7M $6.6M $48.5M -$15.7M $5.3M -$2.0M $91.0M $14.0M $177.7M 2016201720182019202020212022202320242025
Free cash flow
-$26.4M $159000 $19.2M $4.5M -$58.0M -$11.7M -$75.0M $82.1M $147.3M $174.9M 2016201720182019202020212022202320242025

Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$1.4B$1.2B$1.1B$847.1M$747.6M$560.4M$547.4M$444.9M$333.8M$263.3M
Gross profit$942.4M$755.0M$682.6M$535.2M$475.4M$338.2M$372.0M$292.5M$217.1M$170.8M
R&D expense$36.2M$31.7M$23.9M
SG&A expense$663.4M$574.0M$506.5M$449.7M$378.3M$287.1M$272.7M$226.4M$184.3M$148.3M
Operating income$189.2M$9.3M$73.6M$6.1M-$7.5M-$38.9M$47.5M-$852,000$1.2M-$1.4M
Interest expense$1.7M$1.7M$1.9M
Income tax$27.4M$6.9M-$11.3M$5.9M-$13.1M-$18.8M$3.1M-$4.4M-$3.6M-$15.7M
Net income$177.7M$14.0M$91.0M-$2.0M$5.3M-$15.7M$48.5M$6.6M$4.7M$14.8M
EPS (diluted)$4.52$0.36$2.32$-0.05$0.14$-0.44$1.34$0.18$0.13$0.44
Operating cash flow$238.7M$168.5M$97.3M-$55.7M$9.5M-$33.2M$26.7M$28.8M$12.7M-$12.8M
Free cash flow$174.9M$147.3M$82.1M-$75.0M-$11.7M-$58.0M$4.5M$19.2M$159,000-$26.4M
Cash & equivalents$186.9M$324.4M$167.5M$69.9M$59.4M$69.7M$72.8M$67.8M$50.6M$13.2M
Inventory$431.5M$406.7M$388.0M$334.0M$263.5M$219.5M$153.0M$115.7M$94.9M$73.0M
Total assets$1.8B$1.5B$1.6B$1.4B$1.2B$823.0M$665.9M$515.0M$476.7M$308.3M
Total liabilities$398.9M$382.2M$377.4M$372.0M$290.3M$185.2M$180.3M$92.6M$76.3M$41.7M
Shareholders' equity$1.4B$1.2B$1.2B$998.9M$953.9M$641.5M$485.9M$422.4M$400.4M$266.5M

Growth · year-over-year · Revenue CAGR 20.4%

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue growth+17.5%+12.9%+25.0%+13.3%+33.4%+2.4%+23.0%+33.3%+26.8%+41.5%
Net income growth+1168.1%-84.6%-137.9%-132.4%+634.1%+41.7%-68.6%+526.4%
EPS growth+1155.6%-84.5%-135.7%-132.8%+644.4%+38.5%-70.5%+450.0%
Free cash flow growth+18.8%+79.4%-1376.6%-76.3%+11978.6%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.